Healthcare Triangle (HCTI) EBITDA Margin (2020 - 2026)

Healthcare Triangle has disclosed EBITDA Margin across 7 years of filings, most recently posting 42.62% for Q2 2026.

• In Q2 2026, EBITDA Margin fell 442.0% year-over-year to 42.62%; the TTM figure through Jun 2026 stood at 56.11% (down 1585.0% YoY), while the FY2025 annual figure was 70.38%, down 3003.0% from the prior year.
• EBITDA Margin came in at 42.62% for Q2 2026 at Healthcare Triangle, down from 35.11% in the prior quarter.
• In the past five years, EBITDA Margin ranged from a high of 12.36% in Q2 2022 to a low of 141.54% in Q4 2025.
• Average EBITDA Margin over 5 years is 43.17%, with a median of 37.81% recorded in 2025.
• Year-over-year, EBITDA Margin soared 7539 bps in 2023 and plunged 10172 bps in 2025.
• Over 5 years, EBITDA Margin stood at 94.25% in 2022, then surged by 80 bps to 18.87% in 2023, then tumbled by 111 bps to 39.82% in 2024, then slumped by 255 bps to 141.54% in 2025, then soared by 70 bps to 42.62% in 2026.
• Per Business Quant data, the three most recent EBITDA Margin figures were 42.62% in Q2 2026, 35.11% in Q1 2026, and 141.54% in Q4 2025.